Latest California Healthline Stories
Writing Your Way Through Cancer
A breast cancer survivor and author has helped numerous patients explore the feelings awakened by their disease — and feel better.
Nueva droga contra la leucemia ofrece esperanza, pero a un costo millonario
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.
‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Colon Cancer Rates Rising Among Younger White Adults — And Falling Among Blacks
Although deaths from colorectal cancer are declining, researchers find rates of the disease among white men and women younger than 55 have spiked since the mid-1990s.
Safe Under The ACA, Patients With Preexisting Conditions Now Fear Bias
Thinking they were protected from insurance discrimination, many people got tested to see if they were likely to develop serious diseases. Legislation pushed by Republican leaders in Congress would leave them vulnerable.
Seniors Miss Out On Clinical Trials
Among hurdles: Older adults may have multiple illnesses that could complicate research or they might be unable to manage the commute.
Asian-American Women Often Face Delays In Treatment After Worrisome Mammograms
A new study shows that a lower proportion of Asian women get timely follow-up appointments after abnormal mammograms than whites.
‘How Long Have I Got, Doc?’ Why Many Cancer Patients Don’t Have Answers
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
“¿Cuánto tiempo me queda, doctor?” Por qué muchos pacientes con cáncer no obtienen respuestas
Muchas veces los pacientes con cáncer no reciben respuestas adecuadas a preguntas críticas, entre ellas, la más crucial y universal de todas.
As Government-Funded Cancer Research Sags, Scientists Fear U.S. Is ‘Losing Its Edge’
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.